全文获取类型
收费全文 | 2563篇 |
免费 | 103篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 67篇 |
儿科学 | 86篇 |
妇产科学 | 8篇 |
基础医学 | 356篇 |
口腔科学 | 104篇 |
临床医学 | 241篇 |
内科学 | 650篇 |
皮肤病学 | 12篇 |
神经病学 | 211篇 |
特种医学 | 108篇 |
外科学 | 349篇 |
综合类 | 9篇 |
一般理论 | 1篇 |
预防医学 | 132篇 |
眼科学 | 28篇 |
药学 | 130篇 |
中国医学 | 1篇 |
肿瘤学 | 188篇 |
出版年
2023年 | 7篇 |
2022年 | 11篇 |
2021年 | 33篇 |
2020年 | 21篇 |
2019年 | 33篇 |
2018年 | 35篇 |
2017年 | 26篇 |
2016年 | 40篇 |
2015年 | 42篇 |
2014年 | 66篇 |
2013年 | 116篇 |
2012年 | 137篇 |
2011年 | 157篇 |
2010年 | 107篇 |
2009年 | 81篇 |
2008年 | 142篇 |
2007年 | 177篇 |
2006年 | 156篇 |
2005年 | 153篇 |
2004年 | 170篇 |
2003年 | 183篇 |
2002年 | 182篇 |
2001年 | 48篇 |
2000年 | 25篇 |
1999年 | 45篇 |
1998年 | 32篇 |
1997年 | 36篇 |
1996年 | 28篇 |
1995年 | 25篇 |
1994年 | 32篇 |
1993年 | 28篇 |
1992年 | 31篇 |
1991年 | 29篇 |
1990年 | 23篇 |
1989年 | 28篇 |
1988年 | 15篇 |
1987年 | 11篇 |
1986年 | 13篇 |
1985年 | 18篇 |
1984年 | 20篇 |
1983年 | 18篇 |
1982年 | 21篇 |
1981年 | 8篇 |
1980年 | 13篇 |
1979年 | 7篇 |
1978年 | 11篇 |
1977年 | 15篇 |
1976年 | 7篇 |
1975年 | 6篇 |
1957年 | 2篇 |
排序方式: 共有2681条查询结果,搜索用时 8 毫秒
91.
Jose Lopez-Sendon Peter Mills Heinz Weber Rolf Michels Carlo Di Mario Gerasimos S Filippatos Magda Heras Kevin Fox Jose Merino D J Pennell Heinz Sochor Joanna Ortoli Andras Szatmari Fausto Pinto Jan Peder Amlie Ali Oto Mitja Lainscak Kim Fox Peter Kearney Lino Gon?alves Heikki Huikuri Celine Carrera 《European heart journal》2007,28(17):2163-2171
92.
Promoter‐specific alterations of APC are a rare cause for mutation‐negative familial adenomatous polyposis
下载免费PDF全文
![点击此处可从《Genes, chromosomes & cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Annette Gylling Juha‐Pekka Pursiheimo Asta Laiho Attila Gyenesei Heikki J. Järvinen Päivi Peltomäki 《Genes, chromosomes & cancer》2014,53(10):857-864
In familial adenomatous polyposis (FAP), 20% of classical and 70% of attenuated/atypical (AFAP) cases remain mutation‐negative after routine testing; yet, allelic expression imbalance may suggest an APC alteration. Our aim was to determine the proportion of families attributable to genetic or epigenetic changes in the APC promoter region. We studied 51 unrelated families/cases (26 with classical FAP and 25 with AFAP) with no point mutations in the exons and exon/intron borders and no rearrangements by multiplex ligation‐dependent probe amplification (MLPA, P043‐B1). Promoter‐specific events of APC were addressed by targeted resequencing, MLPA (P043‐C1), methylation‐specific MLPA, and Sanger sequencing of promoter regions. A novel 132‐kb deletion encompassing the APC promoter 1B and upstream sequence occurred in a classical FAP family with allele‐specific APC expression. No promoter‐specific point mutations or hypermethylation were present in any family. In conclusion, promoter‐specific alterations are a rare cause for mutation‐negative FAP (1/51, 2%). The frequency and clinical correlations of promoter 1B deletions are poorly defined. This investigation provides frequencies of 1/26 (4%) for classical FAP, 0/25 (0%) for AFAP, and 1/7 (14%) for families with allele‐specific expression of APC. Clinically, promoter 1B deletions may associate with classical FAP without extracolonic manifestations. © 2014 Wiley Periodicals, Inc. 相似文献
93.
Leonora W. de Boo Katarzyna J
wiak Heikki Joensuu Henrik Lindman Susanna Lauttia Mark Opdam Charlaine van Steenis Wim Brugman Roelof J. C. Kluin Philip C. Schouten Marleen Kok Petra M. Nederlof Michael Hauptmann Sabine C. Linn 《British journal of cancer》2022,126(10):1401
Background The addition of adjuvant capecitabine to standard chemotherapy of early-stage triple-negative breast cancer (TNBC) patients has improved survival in a few randomised trials and in meta-analyses. However, many patients did not benefit. We evaluated the BRCA1-like DNA copy number signature, indicative of homologous recombination deficiency, as a predictive biomarker for capecitabine benefit in the TNBC subgroup of the FinXX trial.Methods Early-stage TNBC patients were randomised between adjuvant capecitabine-containing (TX + CEX: capecitabine-docetaxel, followed by cyclophosphamide-epirubicin-capecitabine) and conventional chemotherapy (T + CEF: docetaxel, followed by cyclophosphamide-epirubicin-fluorouracil). Tumour BRCA1-like status was determined on low-coverage, whole genome next-generation sequencing data using an established DNA comparative genomic hybridisation algorithm.Results For 129/202 (63.9%) patients the BRCA1-like status could be determined, mostly due to lack of tissue. During a median follow-up of 10.7 years, 35 recurrences and 32 deaths occurred. Addition of capecitabine appears to improve recurrence-free survival more among 61 (47.3%) patients with non-BRCA1-like tumours (HR 0.23, 95% CI 0.08–0.70) compared to 68 (52.7%) patients with BRCA1-like tumours (HR 0.66, 95% CI 0.24–1.81) (P-interaction = 0.17).Conclusion Based on our data, patients with non-BRCA1-like TNBC appear to benefit from the addition of capecitabine to adjuvant chemotherapy. Patients with BRCA1-like TNBC may also benefit. Additional research is needed to define the subgroup within BRCA1-like TNBC patients who may not benefit from adjuvant capecitabine.Subject terms: Breast cancer, Translational research, Predictive markers, Breast cancer 相似文献
94.
Heikki K. T. Penttilä Karl A. J. Von Smitten Timo H. Waris 《Journal of plastic surgery and hand surgery》2013,47(2):123-128
The disappearance of catecholamine fluorescence from the noradrenaline-containing sympathetic nerve fibres after arterial transplantation was studied using a femoral artery graft sutured to rat carotid artery. Glyoxylic acid-induced fluorescence was used to demonstrate adrenergic nerves histochemically. At six hours the network of fibres had started to degenerate, and catecholamine fluorescence from the adrenergic nerves had almost completely disappeared within 24 hours of grafting. Control specimens from normal femoral arteries showed a dense network of fluorescent adrenergic nerves. Based on observations of the relatively rapid liberation of catecholamines from the degenerating adrenergic nerves, we suggest that catecholamines liberated from degenerating adrenergic nerves may have an important role in early vasospasm in microvascular and coronary bypass surgery. 相似文献
95.
96.
Marja-Leena Kylnp Heikki Repo Pauli Antero Puolakkainen 《World journal of gastroenterology : WJG》2010,16(23):2867-2872
Acute pancreatitis(AP) is a common disease,which usually exists in its mild form.However,in a fifth of cases,the disease is severe,with local pancreatic complications or systemic organ dysfunction or both.Because the development of organ failure is the major cause of death in AP,early identification of patients likely to develop organ failure is important.AP is initiated by intracellular activation of pancreatic proenzymes and autodigestion of the pancreas.Destruction of the pancreatic parenchyma first indu... 相似文献
97.
98.
99.
100.
Qingju Wang Markku Alén Arja Lyytikäinen Leiting Xu Fran A Tylavsky Urho M Kujala Heikki Kröger Ego Seeman Sulin Cheng 《Journal of bone and mineral research》2010,25(7):1512-1520
Familial resemblance and diversity in bone structure and strength in adulthood are determined in part during growth. Whether these characteristics are established during gestation or shortly after birth is not known. Total‐body, lumbar spine, and femoral neck size and mass and indices of tibial bending strength and distal radial compressive strength were measured using bone densitometry and quantitative computed tomography in 236 girls at 18.5 years of age. Among them, 219, 141, and 105 girls had crown‐heel length (CHL) and weight recorded at birth and at 6 and 12 months of age, and then height and weight were recorded at 3, 5, 10, 13, and 15 years of age in 181, 176, 127, 111, and 228 girls, respectively. Of these girls, 101 and 93 girls also had bone structure assessed at 11 and 13 years of age, respectively. Similar bone measurements were made once in 78 mother‐father pairs. CHL and weight at birth did not correlate or did so weakly with bone traits in girls at 18 years of age. By contrast, CHL at 6 months correlated with the height, bone traits, and strength at puberty and at 18 years of age (r = 0.24–0.56, p < .001) in girls and with their parents' height and bone traits (r = 0.15–0.37, p < .05). When the girls' CHL at 6 months was stratified into quartiles, the absolute and relative differences in bone traits observed at puberty (~11.5 years) were maintained as these traits tracked during the ensuing 7 years. Similarly, weight at 6 months correlated with the girls' bone traits at puberty and 18 years of age (r = 0.22–0.55, p < .05). During puberty and at 18 years of age, the girls' bone traits correlated with the corresponding traits in their parents (r = 0.32–0.43, p < .01). It is concluded that familial resemblance in bone structural strength and the position of an individual's bone traits relative to others in adulthood are likely to be established during the first year of life. Thus susceptibility to bone fragility late in life has its antecedents established early in life. © 2010 American Society for Bone and Mineral Research 相似文献